title: Identification and characterization of a -1 reading frameshift in the heavy chain constant region of an IgG1 recombinant monoclonal antibody produced in CHO cells.
abstract: Frameshifts lead to complete alteration of the intended amino acid sequences, and therefore may affect the biological activities of protein therapeutics and pose potential immunogenicity risks. We report here the identification and characterization of a novel -1 frameshift variant in a recombinant IgG1 therapeutic monoclonal antibody (mAb) produced in Chinese hamster ovary cells during the cell line selection studies. The variant was initially observed as an atypical post-monomer fragment peak in size exclusion chromatography. Characterization of the fragment peak using intact and reduced liquid chromatography-mass spectrometry (LC-MS) analyses determined that the fragment consisted of a normal light chain disulfide-linked to an aberrant 26 kDa fragment that could not be assigned to any HC fragment even after considering common modifications. Further analysis using LC-MS/MS peptide mapping revealed that the aberrant fragment contained the expected HC amino acid sequence (1-232) followed by a 20-mer novel sequence corresponding to expression of heavy chain DNA sequence in the -1 reading frame. Examination of the DNA sequence around the frameshift initiation site revealed that a mononucleotide repeat GGGGGG located in the IgG1 HC constant region was most likely the structural root cause of the frameshift. Rapid identification of the frameshift allowed us to avoid use of a problematic cell line containing the frameshift as the production cell line. The frameshift reported here may be observed in other mAb products and the hypothesis-driven analytical approaches employed here may be valuable for rapid identification and characterization of frameshift variants in other recombinant proteins.
authors.affiliation: a Bioproduct Research and Development, Eli Lilly and Company, Lilly Corporate Center , Indianapolis , IN 46285 , USA.
authors.forename: Zhirui
authors.initials: Z
authors.lastname: Lian
authors.affiliation: a Bioproduct Research and Development, Eli Lilly and Company, Lilly Corporate Center , Indianapolis , IN 46285 , USA.
authors.forename: Qindong
authors.initials: Q
authors.lastname: Wu
authors.affiliation: a Bioproduct Research and Development, Eli Lilly and Company, Lilly Corporate Center , Indianapolis , IN 46285 , USA.
authors.forename: Tongtong
authors.initials: T
authors.lastname: Wang
mesh_terms: D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000096:biosynthesis / Q000235:genetics*; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D016368:Frameshift Mutation; D006801:Humans; D007127:Immunoglobulin Constant Regions / Q000096:biosynthesis / Q000235:genetics*; D007074:Immunoglobulin G / Q000096:biosynthesis / Q000235:genetics*; D007143:Immunoglobulin Heavy Chains / Q000096:biosynthesis / Q000235:genetics*; D011994:Recombinant Proteins
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007127:Immunoglobulin Constant Regions; D007074:Immunoglobulin G; D007143:Immunoglobulin Heavy Chains; D011994:Recombinant Proteins
keywords: CHO; G-string; IgG; cell line selection; frameshift; mass spectrometry; monoclonal antibody; mononucleotide repeat; sequence variant